<p>安捷伦科技（NYSE:A - 获取免费报告）在周一发布给客户和投资者的研究报告中，被巴克莱的股票分析师从 “持平” 评级上调至 “增持” 评级，Marketbeat 报道称。该券商目前对这家医疗研究公司的股票设定了 165.00 美元的目标价。巴克莱的目标价意味着该股票当前价格有潜在的 16.66% 的上涨空间。</p>
<ul>
<li>分红强者：3 只为长期投资而生的蓝筹股</li>
</ul>
<p>其他一些股票分析师也最近对该股票发布了报告。TD Cowen 将安捷伦科技的股票目标价从 150.00 美元上调至 162.00 美元，并在 10 月 14 日的报告中给予该公司 “买入” 评级。高盛集团在 12 月 9 日的报告中开始覆盖安捷伦科技的股票，给予 “买入” 评级和 170.00 美元的目标价。瑞银集团在 11 月 25 日的研究报告中将安捷伦科技的目标价从 170.00 美元上调至 180.00 美元，并给予该股票 “买入” 评级。罗斯柴尔德与红烧（Rothschild &amp; Co Redburn）在 10 月 8 日的研究报告中开始覆盖安捷伦科技，给予 “买入” 评级和 165.00 美元的目标价。最后，罗斯柴尔德红烧在 10 月 8 日的研究报告中将安捷伦科技的股票评级提升至 “强力买入”。一位分析师对该股票给予了强力买入评级，十一位分析师给予买入评级，四位分析师给予持有评级。根据 MarketBeat 的数据，该股票目前的平均评级为 “适度买入”，平均目标价为 161.77 美元。</p>
<p>获取 <strong>安捷伦科技</strong> 的提醒：</p>
<p><strong>获取我们对安捷伦科技的最新股票分析</strong></p>
<h2>安捷伦科技股票表现</h2>
<ul>
<li>AST SpaceMobile 为下周的 BlueBird 6 发射做好准备</li>
</ul>
<p>周一，NYSE A 的开盘价为 141.44 美元。该公司的 50 日移动平均价格为 145.59 美元，200 日移动平均价格为 129.27 美元。该公司的速动比率为 1.52，流动比率为 1.96，债务与股本比率为 0.45。该公司的市值为 401 亿美元，市盈率为 30.83，市盈率/增长比率为 4.05，贝塔值为 1.27。安捷伦科技的 52 周低点为 96.43 美元，52 周高点为 160.27 美元。</p>
<p>安捷伦科技（NYSE:A - 获取免费报告）最后一次公布财报是在 11 月 24 日，医疗研究公司报告季度每股收益为 1.59 美元，超出市场共识预期的 1.58 美元 0.01 美元。安捷伦科技的股本回报率为 25.20%，净利润率为 18.75%。该公司季度收入为 18.6 亿美元，而市场共识预期为 18.3 亿美元。去年同期，该公司每股收益为 1.46 美元。该公司的收入同比增长 9.4%。安捷伦科技已将其 2026 年第一季度的指导目标设定为 1.350-1.380 美元每股收益，2026 财年的指导目标设定为 5.860-6.000 美元每股收益。平均而言，股票研究分析师预计安捷伦科技今年每股收益为 5.58 美元。</p>
<h2>内部人士下注</h2>
<ul>
<li>为什么 AutoZone 的股票下跌可能是一个绝佳的买入机会</li>
</ul>
<p>在相关消息中，首席执行官 Padraig Mcdonnell 于 11 月 12 日星期三出售了 12,490 股安捷伦科技的股票。股票以 150.00 美元的平均价格出售，总交易额为 1,873,500.00 美元。交易后，首席执行官在公司中持有 33,448 股，价值约为 5,017,200 美元。此次交易使其持股减少了 27.19%。该交易已在向 SEC 提交的法律文件中披露，您可以通过此链接访问。此外，副总裁 Rodney Gonsalves 于 11 月 26 日星期三出售了 3,000 股公司的股票。该股票以 154.99 美元的平均价格出售，总交易额为 464,970.00 美元。出售后，副总裁直接持有 31,846 股公司的股票，价值约为 4,935,811.54 美元。此次交易使其持股减少了 8.61%。有关此次出售的更多细节可在官方 SEC 披露中找到。在过去三个月中，内部人士出售了价值 2,468,962 美元的 16,401 股公司股票。</p>
<h2>安捷伦科技的机构交易</h2>
<p>对冲基金最近对该公司的持仓进行了调整。Capital A Wealth Management LLC 在第二季度将其在安捷伦科技的股份增加了 10,600.0%。Capital A Wealth Management LLC 现在拥有 214 股医疗研究公司的股票，价值 25,000 美元，此前在该期间内又购买了 212 股。Davis Capital Management 在第三季度获得了安捷伦科技的新股份，价值约 28,000 美元。Physician Wealth Advisors Inc.在第三季度将其在安捷伦科技的股份增加了 490.0%。Physician Wealth Advisors Inc.现在拥有 236 股医疗研究公司的股票，价值 30,000 美元，此前在上个季度又购买了 196 股。Ransom Advisory Ltd 在第一季度获得了安捷伦科技的新股份，价值约 32,000 美元。最后，Central Pacific Bank Trust Division 在第二季度购买了安捷伦科技的新股份，价值约 33,000 美元。</p>
<h2>关于安捷伦科技</h2>
<p>（获取免费报告）</p>
<p>安捷伦科技公司为全球生命科学、诊断和应用化学市场提供应用导向的解决方案。该公司分为三个部门：生命科学与应用市场、诊断与基因组学，以及安捷伦跨实验室。生命科学与应用市场部门提供液相色谱系统及其组件；液相色谱质谱系统；气相色谱系统及其组件；气相色谱质谱系统；感应耦合等离子体质谱仪；原子吸收仪器；微波等离子体 - 原子发射光谱仪；感应耦合等离子体光学发射光谱仪；拉曼光谱仪；细胞分析板基于的检测；流式细胞仪；实时细胞分析仪；细胞成像系统；微孔板读数仪；实验室软件；信息管理与分析；实验室自动化与机器人系统；溶出测试；真空泵和测量技术。</p>
<h2>另见</h2>
<ul>
<li>我们更看好的五只股票，胜过安捷伦科技</li>
<li>基础材料股票投资</li>
<li>GOOGL 的不可阻挡的势头推动价格目标创下新高</li>
<li>如何计算股票利润</li>
<li>3 只被低估的机器人股票，准备迎来巨额收益</li>
<li>最具波动性的股票，投资者需要了解的事项</li>
<li>Dave &amp; Buster’s 的反转在双底突破后进入了游戏状态</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUE?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUE"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1000 美元在安捷伦科技吗？</h2>
<p>在考虑安捷伦科技之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而安捷伦科技并不在名单上。</p>
<p>虽然安捷伦科技目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

安捷伦科技

<p>巴克莱将安捷伦科技的评级上调至 “增持”，目标价为 165 美元，意味着潜在上涨幅度为 16.66%。其他分析师也给予了积极的评级，目标价范围在 162 美元到 180 美元之间。安捷伦的股票表现显示其 52 周区间为 96.43 美元到 160.27 美元，最近的财报超出预期。内部交易方面，首席执行官和副总裁进行了大量股票出售。对冲基金已调整其持仓，持股显著增加</p>

<p>Agilent Technologies (NYSE:A - Get Free Report) was upgraded by stock analysts at Barclays from an &#34;equal weight&#34; rating to an &#34;overweight&#34; rating in a research report issued to clients and investors on Monday, Marketbeat reports. The brokerage currently has a $165.00 price objective on the medical research company's stock. Barclays's target price would indicate a potential upside of 16.66% from the stock's current price.</p>
<div class="lb-trans"><p>安捷伦科技（NYSE:A - 获取免费报告）在周一发布给客户和投资者的研究报告中，被巴克莱的股票分析师从 “持平” 评级上调至 “增持” 评级，Marketbeat 报道称。该券商目前对这家医疗研究公司的股票设定了 165.00 美元的目标价。巴克莱的目标价意味着该股票当前价格有潜在的 16.66% 的上涨空间。</p>
</div><ul>
<li>Dividend Powerhouses: 3 Blue-Chip Stocks Built for the Long Haul</li>
</ul>
<div class="lb-trans"><ul>
<li>分红强者：3 只为长期投资而生的蓝筹股</li>
</ul>
</div><p>A number of other equities analysts also recently issued reports on the stock. TD Cowen increased their price target on shares of Agilent Technologies from $150.00 to $162.00 and gave the company a &#34;buy&#34; rating in a report on Tuesday, October 14th. The Goldman Sachs Group initiated coverage on shares of Agilent Technologies in a report on Tuesday, December 9th. They issued a &#34;buy&#34; rating and a $170.00 target price for the company. UBS Group boosted their price target on Agilent Technologies from $170.00 to $180.00 and gave the stock a &#34;buy&#34; rating in a research note on Tuesday, November 25th. Rothschild &amp; Co Redburn started coverage on Agilent Technologies in a research note on Wednesday, October 8th. They issued a &#34;buy&#34; rating and a $165.00 price objective for the company. Finally, Rothschild Redb raised shares of Agilent Technologies to a &#34;strong-buy&#34; rating in a research report on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and four have given a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of &#34;Moderate Buy&#34; and an average target price of $161.77.</p>
<div class="lb-trans"><p>其他一些股票分析师也最近对该股票发布了报告。TD Cowen 将安捷伦科技的股票目标价从 150.00 美元上调至 162.00 美元，并在 10 月 14 日的报告中给予该公司 “买入” 评级。高盛集团在 12 月 9 日的报告中开始覆盖安捷伦科技的股票，给予 “买入” 评级和 170.00 美元的目标价。瑞银集团在 11 月 25 日的研究报告中将安捷伦科技的目标价从 170.00 美元上调至 180.00 美元，并给予该股票 “买入” 评级。罗斯柴尔德与红烧（Rothschild &amp; Co Redburn）在 10 月 8 日的研究报告中开始覆盖安捷伦科技，给予 “买入” 评级和 165.00 美元的目标价。最后，罗斯柴尔德红烧在 10 月 8 日的研究报告中将安捷伦科技的股票评级提升至 “强力买入”。一位分析师对该股票给予了强力买入评级，十一位分析师给予买入评级，四位分析师给予持有评级。根据 MarketBeat 的数据，该股票目前的平均评级为 “适度买入”，平均目标价为 161.77 美元。</p>
</div><p>Get <strong>Agilent Technologies</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>安捷伦科技</strong> 的提醒：</p>
</div><p><strong>Get Our Latest Stock Analysis on Agilent Technologies</strong></p>
<div class="lb-trans"><p><strong>获取我们对安捷伦科技的最新股票分析</strong></p>
</div><h2>Agilent Technologies Stock Performance</h2>
<div class="lb-trans"><h2>安捷伦科技股票表现</h2>
</div><ul>
<li>AST SpaceMobile Gears Up for Its BlueBird 6 Launch Next Week</li>
</ul>
<div class="lb-trans"><ul>
<li>AST SpaceMobile 为下周的 BlueBird 6 发射做好准备</li>
</ul>
</div><p>NYSE A opened at $141.44 on Monday. The business's 50-day moving average price is $145.59 and its 200 day moving average price is $129.27. The company has a quick ratio of 1.52, a current ratio of 1.96 and a debt-to-equity ratio of 0.45. The firm has a market cap of $40.10 billion, a P/E ratio of 30.83, a P/E/G ratio of 4.05 and a beta of 1.27. Agilent Technologies has a 52-week low of $96.43 and a 52-week high of $160.27.</p>
<div class="lb-trans"><p>周一，NYSE A 的开盘价为 141.44 美元。该公司的 50 日移动平均价格为 145.59 美元，200 日移动平均价格为 129.27 美元。该公司的速动比率为 1.52，流动比率为 1.96，债务与股本比率为 0.45。该公司的市值为 401 亿美元，市盈率为 30.83，市盈率/增长比率为 4.05，贝塔值为 1.27。安捷伦科技的 52 周低点为 96.43 美元，52 周高点为 160.27 美元。</p>
</div><p>Agilent Technologies (NYSE:A - Get Free Report) last announced its earnings results on Monday, November 24th. The medical research company reported $1.59 earnings per share for the quarter, beating the consensus estimate of $1.58 by $0.01. Agilent Technologies had a return on equity of 25.20% and a net margin of 18.75%.The company had revenue of $1.86 billion for the quarter, compared to the consensus estimate of $1.83 billion. During the same period last year, the business posted $1.46 EPS. The company's revenue was up 9.4% on a year-over-year basis. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. On average, equities research analysts expect that Agilent Technologies will post 5.58 earnings per share for the current year.</p>
<div class="lb-trans"><p>安捷伦科技（NYSE:A - 获取免费报告）最后一次公布财报是在 11 月 24 日，医疗研究公司报告季度每股收益为 1.59 美元，超出市场共识预期的 1.58 美元 0.01 美元。安捷伦科技的股本回报率为 25.20%，净利润率为 18.75%。该公司季度收入为 18.6 亿美元，而市场共识预期为 18.3 亿美元。去年同期，该公司每股收益为 1.46 美元。该公司的收入同比增长 9.4%。安捷伦科技已将其 2026 年第一季度的指导目标设定为 1.350-1.380 美元每股收益，2026 财年的指导目标设定为 5.860-6.000 美元每股收益。平均而言，股票研究分析师预计安捷伦科技今年每股收益为 5.58 美元。</p>
</div><h2>Insiders Place Their Bets</h2>
<div class="lb-trans"><h2>内部人士下注</h2>
</div><ul>
<li>Why AutoZone’s Stock Drop Could Be a Golden Buying Opportunity</li>
</ul>
<div class="lb-trans"><ul>
<li>为什么 AutoZone 的股票下跌可能是一个绝佳的买入机会</li>
</ul>
</div><p>In related news, CEO Padraig Mcdonnell sold 12,490 shares of Agilent Technologies stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $150.00, for a total transaction of $1,873,500.00. Following the transaction, the chief executive officer owned 33,448 shares in the company, valued at approximately $5,017,200. The trade was a 27.19% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, VP Rodney Gonsalves sold 3,000 shares of the company's stock in a transaction on Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total transaction of $464,970.00. Following the sale, the vice president directly owned 31,846 shares of the company's stock, valued at approximately $4,935,811.54. This trade represents a 8.61% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 16,401 shares of company stock worth $2,468,962.</p>
<div class="lb-trans"><p>在相关消息中，首席执行官 Padraig Mcdonnell 于 11 月 12 日星期三出售了 12,490 股安捷伦科技的股票。股票以 150.00 美元的平均价格出售，总交易额为 1,873,500.00 美元。交易后，首席执行官在公司中持有 33,448 股，价值约为 5,017,200 美元。此次交易使其持股减少了 27.19%。该交易已在向 SEC 提交的法律文件中披露，您可以通过此链接访问。此外，副总裁 Rodney Gonsalves 于 11 月 26 日星期三出售了 3,000 股公司的股票。该股票以 154.99 美元的平均价格出售，总交易额为 464,970.00 美元。出售后，副总裁直接持有 31,846 股公司的股票，价值约为 4,935,811.54 美元。此次交易使其持股减少了 8.61%。有关此次出售的更多细节可在官方 SEC 披露中找到。在过去三个月中，内部人士出售了价值 2,468,962 美元的 16,401 股公司股票。</p>
</div><h2>Institutional Trading of Agilent Technologies</h2>
<div class="lb-trans"><h2>安捷伦科技的机构交易</h2>
</div><p>Hedge funds have recently made changes to their positions in the company. Capital A Wealth Management LLC increased its stake in Agilent Technologies by 10,600.0% during the 2nd quarter. Capital A Wealth Management LLC now owns 214 shares of the medical research company's stock worth $25,000 after buying an additional 212 shares during the period. Davis Capital Management acquired a new stake in shares of Agilent Technologies during the third quarter valued at about $28,000. Physician Wealth Advisors Inc. increased its position in shares of Agilent Technologies by 490.0% during the third quarter. Physician Wealth Advisors Inc. now owns 236 shares of the medical research company's stock worth $30,000 after acquiring an additional 196 shares during the last quarter. Ransom Advisory Ltd acquired a new position in shares of Agilent Technologies in the first quarter worth about $32,000. Finally, Central Pacific Bank Trust Division purchased a new position in Agilent Technologies in the second quarter valued at about $33,000.</p>
<div class="lb-trans"><p>对冲基金最近对该公司的持仓进行了调整。Capital A Wealth Management LLC 在第二季度将其在安捷伦科技的股份增加了 10,600.0%。Capital A Wealth Management LLC 现在拥有 214 股医疗研究公司的股票，价值 25,000 美元，此前在该期间内又购买了 212 股。Davis Capital Management 在第三季度获得了安捷伦科技的新股份，价值约 28,000 美元。Physician Wealth Advisors Inc.在第三季度将其在安捷伦科技的股份增加了 490.0%。Physician Wealth Advisors Inc.现在拥有 236 股医疗研究公司的股票，价值 30,000 美元，此前在上个季度又购买了 196 股。Ransom Advisory Ltd 在第一季度获得了安捷伦科技的新股份，价值约 32,000 美元。最后，Central Pacific Bank Trust Division 在第二季度购买了安捷伦科技的新股份，价值约 33,000 美元。</p>
</div><h2>About Agilent Technologies</h2>
<div class="lb-trans"><h2>关于安捷伦科技</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.</p>
<div class="lb-trans"><p>安捷伦科技公司为全球生命科学、诊断和应用化学市场提供应用导向的解决方案。该公司分为三个部门：生命科学与应用市场、诊断与基因组学，以及安捷伦跨实验室。生命科学与应用市场部门提供液相色谱系统及其组件；液相色谱质谱系统；气相色谱系统及其组件；气相色谱质谱系统；感应耦合等离子体质谱仪；原子吸收仪器；微波等离子体 - 原子发射光谱仪；感应耦合等离子体光学发射光谱仪；拉曼光谱仪；细胞分析板基于的检测；流式细胞仪；实时细胞分析仪；细胞成像系统；微孔板读数仪；实验室软件；信息管理与分析；实验室自动化与机器人系统；溶出测试；真空泵和测量技术。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另见</h2>
</div><ul>
<li>Five stocks we like better than Agilent Technologies</li>
<li>Basic Materials Stocks Investing</li>
<li>GOOGL's Unstoppable Momentum Drives Price Targets to Record Highs</li>
<li>How to Calculate Stock Profit</li>
<li>3 Underrated Robotics Stocks Poised for Huge Gains</li>
<li>Most Volatile Stocks, What Investors Need to Know</li>
<li>Dave &amp; Buster’s Reversal Is in PLAY After Double-Bottom Breakout</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，胜过安捷伦科技</li>
<li>基础材料股票投资</li>
<li>GOOGL 的不可阻挡的势头推动价格目标创下新高</li>
<li>如何计算股票利润</li>
<li>3 只被低估的机器人股票，准备迎来巨额收益</li>
<li>最具波动性的股票，投资者需要了解的事项</li>
<li>Dave &amp; Buster’s 的反转在双底突破后进入了游戏状态</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUE" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&amp;Symbol=A"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Agilent Technologies Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在安捷伦科技吗？</h2>
</div><p>Before you consider Agilent Technologies, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑安捷伦科技之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilent Technologies wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而安捷伦科技并不在名单上。</p>
</div><p>While Agilent Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然安捷伦科技目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

安捷伦科技（NYSE:A）在巴克莱被上调评级